- Home
- PAYO vs ALVO Comparison
PAYO vs ALVO Comparison
Compare PAYO & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYO
- ALVO
- Stock Information
- Founded
- PAYO 2005
- ALVO 2013
- Country
- PAYO United States
- ALVO Luxembourg
- Employees
- PAYO N/A
- ALVO N/A
- Industry
- PAYO EDP Services
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- PAYO Technology
- ALVO Health Care
- Exchange
- PAYO Nasdaq
- ALVO Nasdaq
- Market Cap
- PAYO 2.3B
- ALVO 2.5B
- IPO Year
- PAYO N/A
- ALVO N/A
- Fundamental
- Price
- PAYO $6.07
- ALVO $8.63
- Analyst Decision
- PAYO Strong Buy
- ALVO Strong Buy
- Analyst Count
- PAYO 8
- ALVO 1
- Target Price
- PAYO $10.06
- ALVO $14.00
- AVG Volume (30 Days)
- PAYO 3.1M
- ALVO 361.1K
- Earning Date
- PAYO 11-04-2025
- ALVO 11-12-2025
- Dividend Yield
- PAYO N/A
- ALVO N/A
- EPS Growth
- PAYO N/A
- ALVO N/A
- EPS
- PAYO 0.25
- ALVO 0.22
- Revenue
- PAYO $1,017,244,000.00
- ALVO $562,478,000.00
- Revenue This Year
- PAYO $9.34
- ALVO $36.61
- Revenue Next Year
- PAYO $7.48
- ALVO $42.26
- P/E Ratio
- PAYO $24.21
- ALVO $39.49
- Revenue Growth
- PAYO 13.02
- ALVO 82.19
- 52 Week Low
- PAYO $5.71
- ALVO $7.35
- 52 Week High
- PAYO $11.29
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- PAYO 37.54
- ALVO 57.22
- Support Level
- PAYO $5.93
- ALVO $8.03
- Resistance Level
- PAYO $6.30
- ALVO $8.44
- Average True Range (ATR)
- PAYO 0.20
- ALVO 0.30
- MACD
- PAYO -0.04
- ALVO 0.06
- Stochastic Oscillator
- PAYO 16.75
- ALVO 55.33
About PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.